Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells
Open Access
- 1 December 2004
- journal article
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 5 (4) , 176-182
- https://doi.org/10.3317/jraas.2004.037
Abstract
Introduction Angiotensin II (Ang II) is recognised as a regulator of haematopoiesis, but its actions within the bone marrow are not fully understood. Support of haematopoiesis by bone marrow stromal cells (MSC) is dependent on factors that include arachidonic acid and macrophage colony stimulating factor (MCSF), both of which are increased by Ang II stimulation in other tissues. To further elucidate the mechanisms of Ang II-regulated haematopoiesis, we determined whether Ang II-stimulation alters arachidonic acid release and MCSF secretion from MSC.Methods Cynomolgus monkey MSC isolated from bone marrow aspirates and the human HS-5 stromal cell line were studied for Ang II-mediated arachidonic acid (AA) release, while secretion of MCSF in response to Ang II was studied in HS-5 cells. Cells were labelled overnight with3H-AA and the release of3H-AA was measured in culture medium following 20 minutes stimulation with Ang II, alone or in combination with the AT1- or AT2-receptor antagonists, losartan and PD 123319, respectively. MCSF secretion into culture medium was measured using an enzyme immunoassay following 24 hours of treatment with Ang II alone or in combination with losartan or PD 123319. Phorbol-myristate-acetate, known to stimulate release of AA and MCSF, was used as a positive control in both experiments.Results In response to Ang II, release of3H-AA from monkey and human MSC was increased (p1- and AT2-receptor antagonists, losartan and PD 123319, individually reduced Ang II-stimulated3H-AA release. In contrast, Ang II had no effect on secretion of MCSF from HS-5 cells.Conclusions These results provide mechanistic evidence for Ang II-mediated haematopoiesis through AA release that may, in part, explain Ang II-facilitated recovery of haematopoiesis in experimental myelosuppression and the anaemias associated with Ang II receptor blockade.Keywords
This publication has 46 references indexed in Scilit:
- Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.Current Topics in Medicinal Chemistry, 2004
- Towards the understanding of the local hematopoietic bone marrow renin-angiotensin systemThe International Journal of Biochemistry & Cell Biology, 2003
- Absence of angiotensin II type 1 receptor in bone marrow–derived cells is detrimental in the evolution of renal fibrosisJournal of Clinical Investigation, 2002
- Accelerated recovery from irradiation injury by angiotensin peptidesCancer Chemotherapy and Pharmacology, 2002
- Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient miceJournal of Clinical Investigation, 2000
- ACE Inhibitors and Anemia in Congestive Heart FailureCongestive Heart Failure, 2000
- EXPRESSION OF ANGIOTENSIN II TYPE I RECEPTOR ON ERYTHROID PROGENITORS OF PATIENTS WITH POST TRANSPLANT ERYTHROCYTOSIS1Transplantation, 2000
- Captopril Inhibits the Proliferation of Hematopoietic Stem and Progenitor Cells in Murine Long‐Term Bone Marrow CulturesThe International Journal of Cell Cloning, 1999
- Effect of losartan on haemoglobin concentration in renal transplant recipients--a retrospective analysis.Nephrology Dialysis Transplantation, 1997
- Effects of the angiotensin‐converting enzyme inhibitor enalapril on blood haematopoietic progenitors and Acetyl‐N‐Ser‐Asp‐Lys‐Pro concentrationsEuropean Journal of Clinical Investigation, 1997